Tenaya Therapeutics, Inc.

Tenaya Therapeutics, Inc.

TNYA·NASDAQ

$0.79

+1.6%
HealthcareBiotechnology

Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by haploinsufficient myosin binding protein C3 (MYBPC3) gene mutations; and TN-301, a small molecule inhibitor of histone deacetylase 6 (HDAC6i) for use in heart failure with preserved ejection fraction (HFpEF) and genetic dilated cardiomyopathy (gDCM). It is also developing TN-401, an AAV-based gene therapy that addresses genetic arrhythmogenic right ventricular cardiomyopathy (gARVC) caused by plakophilin 2 (PKP2) gene mutations; an AAV-based gene therapy designed to deliver the dwarf open reading frame (DWORF) gene in the heart for DCM; and Reprogramming program, an AAV-based approach for cardiac regeneration to replace heart cells lost in patients experiencing heart failure due to prior myocardial infarction. The company was incorporated in 2016 and is headquartered in South San Francisco, California.

At a Glance

Live Snapshot
Market Cap$130.92M
EPS-0.5900
P/E Ratio-1.33
Earnings Date08/05/2026

No Dividend Yield Data

TNYA has not reported any dividend yield values in the available annual periods.

No Dividend Payout Ratio Data

TNYA has not reported any dividend payout ratio values in the available annual periods.

No Net Dividends Paid Data

TNYA has not reported any net dividends paid values in the available annual periods.

Tenaya Therapeutics, Inc.

Tenaya Therapeutics, Inc. Dividend History

TNYA · NASDAQ
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%

TNYA Dividend Payment History

TNYA · NASDAQ
DeclarationEx-DatePayment DateDividendAdjustedFrequencyGrowth
No dividend payment history available
tnya

Tenaya Therapeutics, Inc. Payout Ratio Analysis

TNYA · NASDAQ
Dividends Paid
0.00
2025
Net Income
-90.60M
2025
Payout Ratio
0.00%
2025

Dividend Sustainability Analysis

Payout Ratio
0.00%

Conservative payout with excellent safety margin. Company retains significant earnings for growth, acquisitions, or building cash reserves. Dividend is highly sustainable.

FCF Payout Ratio
0.0%

Negative free cash flow while paying dividends is a major red flag. Company burning cash and cannot sustain dividend without external financing.

Sustainability
At Risk

Dividend appears unsustainable based on current metrics. High probability of reduction or elimination. Proceed with caution.